Overview
Youcef Mehellou practices practicing medicine in Cardiff, United Kingdom.
His clinical expertise encompasses Parkinson's Disease, Triple-Negative Breast Cancer, and Movement Disorders.
He is actively involved in clinical research, co-authoring 34 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Youcef Mehellou
Is Youcef Mehellou a top-rated expert for Parkinson's Disease?
MediFind is an objective health platform that identifies experts based on real-world data. Youcef Mehellou is classified as an Experienced expert for Parkinson's Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Youcef Mehellou participate in research or clinical trials?
Yes. Youcef Mehellou has published 34 articles and abstracts on conditions like Parkinson's Disease. You can view a list of Youcef Mehellou's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Movement DisordersMr. Mehellou isExperienced. Learn about Movement Disorders.
- Parkinson's DiseaseMr. Mehellou isExperienced. Learn about Parkinson's Disease.
- Triple-Negative Breast CancerMr. Mehellou isExperienced. Learn about Triple-Negative Breast Cancer.